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Background: It has been reported that in patients (pts) on hemodialysis (HD) coronary artery bypass grafting (CABG) produce better long term 
survival and lower major adverse cardiovascular event (MACE) than percutaneous coronary intervention (PCI). Large studies on long term outcomes 
comparing CABG to PCI using drug eluting stents (DES) are lacking.
Methods: Data from New Jersey MIDAS database and chronic HD network was used to identify 2,185 pts on HD who received first 
revascularization procedures (CABG or PCI) between 2003 and 2009. All-cause mortality as well as MACE were analyzed at 30-day, 1 and 2 year.
Results: Among the 2,185 HD pts, 536 received CABG, 1,155 DES, and 494 bare metal stent (BMS). Clinical characteristics were not different 
among groups. Reasons for HD were: 54.7% diabetic kidney disease, 26.4% hypertensive kidney disease, 12.1% glomerulonephritis, and 6.8% other 
conditions. The figure shows that in HD pts, DES had lower in-hospital and 1-year mortality compared to CABG and similar mortality at 2 years. The 
incidence of MACE was significantly higher in DES and BMS than CABG, both at 30-day and at 2-year follow-up.
Conclusions: Thus in HD pts the use of DES resulted in a better short term and equal long-term survival compared to CABG. In the era of DES, the 
optimal revascularization strategy for this subset of pts with limited expected survival warrants further study.
